1. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006. 1:S. S4–S8.
Article
2. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA. 2001. 98:8160–8162.
Article
3. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, et al. Regulation of iron homeostasis in anemia of chronic disorder and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009. 113:5277–5285.
4. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002. 29:327–335.
Article
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003. 101:2461–2463.
Article
6. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002. 110:1037–1044.
Article
7. Grebenchtchikov N, Geurts-Moespot AJ, Kroot JJ, den Heijer M, Tjalsma H, Swinkels DW, et al. High-sensitive radioimmunoassay for human serum hepcidin. Br J Haematol. 2009. 146:317–325.
Article
8. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004. 53:735–743.
Article
9. Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, Nii-Kono T, et al. Serum pro-hepcidin as an indicator of iron status in dialysis patients. Ther Apher Dial. 2008. 12:226–231.
Article
10. Orhon FS, Ulukol B, Hanoluk A, Akar N. Serum pro-hepcidin levels in infant with iron deficiency anaemia. Int J Lab Hematol. 2008. 30:546–547.
11. Sasu BJ, Li H, Rose MJ, Arvedson TL, Doellgast G, Molineux G. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol Dis. 2010. 45:238–245.
Article
12. Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol. 2008. 28:115–121.
Article
13. Ryu EY, Jang SH, Yeom JS, Park ES, Seo JH, Lim JY, et al. Correlation between pro-hepcidin level and iron parameter in infant patients with iron deficiency anemia and anemia-free infants. Clin Pediatr Hematol-Oncol. 2007. 14:145–150.
14. Paesano R, Berlutti F, Pietropaoli M, Pantanella F, Pacifici E, Goolsbee W, et al. Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women. Biometals. 2010. 23:411–417.
Article
15. Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood. 2006. 107:4142–4148.
Article
16. Cook DJ, Skikne BS. Iron deficiency: definition and diagnosis. J Intern Med. 1989. 226:349–355.
Article
17. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997. 277:973–976.
Article
18. Ganz T, Olibina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008. 112:4292–4297.
Article
19. Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurement in serum and urine: analytical aspects and clinical implication. Clin Chem. 2007. 53:620–628.
Article
20. Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, et al. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med. 2010. 36:1044–1048.
Article
21. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med. 2011. 11:33–42.
Article
22. Means RT Jr. Hepcidin and anaemia. Blood Rev. 2004. 18:219–225.
Article
23. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997. 89:1052–1057.
Article
24. Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J Haematol. 2003. 122:996–1000.
Article
25. Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol. 2005. 25:586–590.
Article
26. Ulukol B, Orhon FS, Hanoluk A, Akar N. Serum pro-hepcidin levels and relationship with ferritin in healthy non-anaemic infants. Acta Haematol. 2007. 118:70–72.
Article
27. Kim HR, Kim KW, Yoon SY, Kim SH, Lee SH. Serum pro-hepcidin could reflect disease activity in patients with rheumatoid arthritis. J Korean Med Sci. 2010. 25:348–352.
Article
28. Chung J. Relationship between serum pro-hepcidin concentration and body iron status in female college students. Korean J Nutr. 2005. 38:750–755.